The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant taxane therapy for early-stage breast cancer: A real-world comparison of chemotherapy regimens in Ontario.
Sofia Torres
No relevant relationships to disclose
Maureen E. Trudeau
No relevant relationships to disclose
Andrea Eisen
No relevant relationships to disclose
Craig Earle
No relevant relationships to disclose
Kelvin K. Chan
No relevant relationships to disclose